Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2002Hepatology

PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival

View Full Paper
Ask AI
Bookmark
Share

Authors

ACAlexandre CoutantInsermCRClaude RescanNovo Nordisk (Denmark)DGDavid GilotInserm

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Coutant et al. (2002) studied this question.

synapsesocial.com/papers/6a962dfe3c640d92aed7c465https://doi.org/10.1053/jhep.2002.36160
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ribosomal S6 Kinase 2 Inhibition by a Potent C-terminal Repressor Domain Is Relieved by Mitogen-activated Protein-Extracellular Signal-regulated Kinase Kinase-regulated Phosphorylation2001 · 67 citations
  2. 2Differentiation Stage-Specific Inhibition of the Raf-MEK-ERK Pathway by Akt1999 · 771 citations
  3. 3Inhibition of Rat Hepatocyte Proliferation by Transforming Growth Factor β and Glucagon Is Associated With Inhibition of Erk2 and P70 S6 Kinase1999 · 49 citations